BioMark Diagnostics Inc.
BUX
주식 순위
#26711
BioMark Diagnostics Inc. is an oncology specialist, developing advanced... BioMark Diagnostics Inc. is an oncology specialist, developing advanced diagnostic tools for cancer to enable early detection, continuous patient monitoring, and the assessment of initial treatment efficacy. The firm holds a research partnership with the Icahn School of Medicine, collaborating on clinical trials specifically addressing the early identification of lung cancer. Founded in 2014, its corporate headquarters are situated in Richmond, Canada. BioMark Diagnostics Inc. operates as a subsidiary of Biomark Technologies Inc.
주가
$0.33433516
마지막 동기화: 2026-10-20
시가총액
$35.60M
변동 (1일)
-3.08%
변동 (1년)
39.31%
국가
CA
거래 BioMark Diagnostics Inc. (BUX)
카테고리
Healthcare
BioMark Diagnostics Inc. (BUX)의 주가 이력
최고 종가: $0.38 (2026-10-01 기준)
최저 종가: $0.35 (2015-03-01 기준)
최저 종가: $0.35 (2015-03-01 기준)
BioMark Diagnostics Inc.의 주가 이력 (2015 ~ 2026)
연간 주가 성과
| 연도 | 성과 |
|---|---|
| 2026 (TTM) | 6.88% |
| 2025 | 136.71% |
| 2024 | -19.87% |
| 2023 | 29.58% |
| 2022 | -34.72% |
| 2021 | 122.09% |
| 2020 | -51.07% |
| 2019 | 376.19% |
| 2018 | -44.93% |
| 2017 | -9.77% |
| 2016 | -22.98% |
| 2015 | 0.00% |
유사 기업 또는 경쟁사의 주가
| 회사 | 주가 | 변동률 1년% | 국가 |
|---|---|---|---|
| $694.53 | 22.45% |
US
|
|
| $234.00 | 7.29% |
US
|
|
| $416.01 | 121.26% |
US
|
|
| $22.06 | 55.84% |
CN
|
|
| $177.93 | 21.98% |
US
|
